So you’ve done your research on BPC-157, read the promising studies, and decided you want to try it. Now comes the question that sends most people down a rabbit hole of forum posts and conflicting advice: how much should you actually take?

Here’s the honest truth upfront. We don’t have FDA-approved dosing guidelines for BPC-157 because it hasn’t gone through human clinical trials for approval. What we do have is a combination of animal research, anecdotal reports from thousands of users, and some basic pharmacological principles we can apply.

Let’s break down what we actually know.

What the animal research tells us

Most BPC-157 studies have been conducted on rats and mice. Researchers typically use doses ranging from 10 micrograms per kilogram (mcg/kg) of body weight on the lower end to 50 mcg/kg on the higher end. Some studies push up to 100 mcg/kg or beyond.

When scientists convert animal doses to human equivalents, they don’t just scale by weight. A 200-pound human isn’t simply a 2,000-gram rat multiplied out. The conversion involves something called body surface area, which accounts for differences in metabolism between species.

Using standard conversion formulas, that 10-50 mcg/kg rat dose translates to roughly 1.6-8 mcg/kg for humans. For a 180-pound person (about 82 kg), that works out to approximately 130-650 mcg per day.

The practical takeaway: Animal research points toward a pretty wide effective range, with most translated human doses falling between 150-600 mcg daily.

What people are actually doing

Spend time in peptide communities and you’ll see dosing protocols all over the map. But some patterns emerge.

The most common approach is 250-500 mcg once or twice daily. Many users report taking 250 mcg in the morning and 250 mcg in the evening, totaling 500 mcg per day. Others stick with a single daily dose of 250-300 mcg.

Some people push higher, into the 750-1000 mcg daily range, especially when dealing with more significant injuries. Others take a conservative approach with 150-200 mcg once daily.

Cycle length typically runs 4-12 weeks. The most popular protocol seems to be 4-6 weeks on, followed by a break of similar length before resuming if needed.

The practical takeaway: Most self-experimenters land somewhere in the 250-500 mcg per day range, split into one or two doses.

Injection vs. oral: does the route change the dose?

This is where things get interesting. BPC-157 is one of the few peptides that shows activity through oral administration, not just injection. But the dosing considerations differ between routes.

With subcutaneous injection, the peptide enters your system directly. Bioavailability is high, meaning most of what you inject actually reaches your tissues. This is why injectable doses tend to be on the lower end of the range.

Oral BPC-157 has to survive your stomach acid and get absorbed through your gut lining. The peptide is remarkably stable compared to most peptides, which typically get destroyed in digestion. Still, oral bioavailability is lower than injection.

Some users compensate by taking higher oral doses, often 500-1000 mcg or more. Others argue that for gut-related issues specifically, oral administration might actually be preferable since it delivers the peptide directly to the tissue you’re trying to help.

The practical takeaway: If you’re injecting, standard doses are 250-500 mcg daily. If you’re going oral, many people double that amount to account for lower absorption.

Local vs. systemic: where you inject matters

A question that comes up constantly is whether you should inject near the injury site or if it doesn’t matter. The research offers some guidance here.

BPC-157 appears to work through systemic mechanisms. It influences growth factors, blood vessel formation, and cellular signaling pathways throughout your body. Studies have shown healing effects even when the peptide is administered far from the injury site.

That said, local injection delivers a higher initial concentration to the target tissue. Think of it like the difference between taking aspirin for a headache versus applying ice directly to a sprained ankle. Both help, but one is more targeted.

For muscle and tendon injuries, many users inject subcutaneously as close to the problem area as practical. For general recovery or gut issues, injection site seems less critical.

The practical takeaway: Systemic effects mean injection site isn’t make-or-break, but local administration may provide some additional benefit for localized injuries.

Building a sensible starting protocol

If you’re new to BPC-157, here’s how to think about building your approach.

Start conservative. There’s no prize for taking the maximum dose on day one. Beginning with 250 mcg once daily lets you assess how your body responds before committing to higher amounts. You can always increase. You can’t un-take something.

Consider your goals. Recovering from a significant tendon injury? You might lean toward the higher end of the range or twice-daily dosing. Using it for general gut support? A lower, once-daily dose might be sufficient.

Time it consistently. Whether you choose morning, evening, or split dosing, try to maintain the same schedule. This helps you track effects and keeps blood levels more stable.

Track what you’re doing. Keep notes on your dose, timing, injection site, and how you feel. Memory is unreliable, especially over weeks-long protocols. Simple notes make it much easier to adjust your approach.

The practical takeaway: Start with 250 mcg once daily, give it at least a week, then adjust based on your response and goals.

What we still don’t know

Being honest about the gaps matters. We don’t have long-term human safety data for BPC-157 at any dose. We don’t know the optimal cycle length or whether cycling is even necessary. We don’t have head-to-head comparisons of different dosing strategies in humans.

The existing research is promising but preliminary. Most studies are short-term and conducted in animals. The handful of human studies that exist used different preparations and protocols, making direct comparisons difficult.

This doesn’t mean BPC-157 is dangerous or ineffective. It means we’re working with incomplete information, and your approach should reflect that reality.

The practical takeaway: Treat any protocol as an experiment. Monitor yourself carefully, and don’t assume that more is automatically better.

When to reconsider your approach

Some situations warrant adjusting your dose or pausing altogether.

If you experience unusual side effects like significant fatigue, digestive upset, or anything that feels off, back down on the dose or take a break. Most people report minimal side effects, but everyone’s biology is different.

If you see no benefit after 3-4 weeks at a reasonable dose, consider whether your expectations were realistic, whether your product quality is reliable, or whether BPC-157 simply isn’t the right tool for your situation. Not everything works for everyone.

If you’re dealing with a serious injury or medical condition, work with a healthcare provider who understands peptides. They can help you monitor your progress and catch any issues you might miss on your own.

The bottom line

BPC-157 dosing isn’t an exact science right now. The research points toward a range of roughly 150-600 mcg daily for humans, and real-world users typically land at 250-500 mcg per day, either as a single dose or split morning and evening.

Start on the lower end, pay attention to your body, and adjust from there. Keep good records. Stay skeptical of anyone claiming to have the “perfect” protocol.

The goal isn’t to find some magical optimal dose. It’s to find what works for your body, your goals, and your situation.